We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lack of DNA Building Blocks Promotes Cancer Cell Formation

By LabMedica International staff writers
Posted on 16 May 2011
Factors causing depletion of the nucleotide building blocks of DNA have been linked to the initiation of processes that cause normal cells to become cancerous.

Investigators at the Hebrew University of Jerusalem (Israel) worked with cell cultures that were put under stress when the Rb-E2F signaling pathway was aberrantly activated. Aberrant activation of this pathway by HPV-16 E6/E7 (human papillomavirus) or cyclin E oncogenes significantly decreased the cellular nucleotide levels. The cells making up these cultures were prone to transform spontaneously into cancer cells.

The investigators reported in the April 29, 2011, issue of the journal Cell that supplying exogenously nucleosides to the cell cultures eliminated the replication stress and DNA damage and dramatically decreased oncogene-induced transformation into cancer cells. Increased transcription of nucleotide biosynthesis genes, mediated by expressing the transcription factor c-myc, increased the nucleotide pool and also rescued the replication-induced DNA damage.

The authors concluded that, "This work raises the possibility for developing new approaches for protection against precancerous development, even possibly creating a kind of treatment to decrease DNA breakage.”

Related Links:

Hebrew University of Jerusalem






New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Automatic CLIA Analyzer
Shine i6000

Latest BioResearch News

Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
16 May 2011  |   BioResearch

Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
16 May 2011  |   BioResearch

Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
16 May 2011  |   BioResearch